Belpointe Asset Management LLC Catalent, Inc. Transaction History

Belpointe Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $11,178 - $18,267	246 Added 102.93%	485 $31,000
Q4 2022 Feb 08, 2023	BUY	$41.39 - $81.0 $9,892 - $19,359	239 New	239 $10,000
Q1 2022 Apr 28, 2022	SELL	$94.19 - $124.49 $309,319 - $408,825	-3,284 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$119.57 - $139.07 $56,676 - $65,919	474 Added 16.87%	3,284 $420,000
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $306,767 - $400,003	2,810 New	2,810 $374,000
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $502,655 - $616,672	-5,853 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$72.74 - $92.5 $425,747 - $541,402	5,853 New	5,853 $501,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.